Myelodysplasia following treatment of chronic lymphocytic leukemia (CLL) with 2-chlorodeoxyadenosine (2-CdA) [1]

S. H. Kroft; M. S. Tallman; J. M. Shaw; M. Thangavelu; L. C. Peterson

doi:10.1038/sj.leu.2400523

Myelodysplasia following treatment of chronic lymphocytic leukemia (CLL) with 2-chlorodeoxyadenosine (2-CdA) [1]

S. H. Kroft^*, M. S. Tallman, J. M. Shaw, M. Thangavelu, L. C. Peterson

^*Corresponding author for this work

Pathology

Research output: Contribution to journal › Letter › peer-review

23 Scopus citations

Original language	English (US)
Pages (from-to)	170
Number of pages	1
Journal	Leukemia
Volume	11
Issue number	1
DOIs	https://doi.org/10.1038/sj.leu.2400523
State	Published - 1997

ASJC Scopus subject areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/sj.leu.2400523

Cite this

@article{adbe01055df349669fee382819f6983c,

title = "Myelodysplasia following treatment of chronic lymphocytic leukemia (CLL) with 2-chlorodeoxyadenosine (2-CdA) [1]",

author = "Kroft, \{S. H.\} and Tallman, \{M. S.\} and Shaw, \{J. M.\} and M. Thangavelu and Peterson, \{L. C.\}",

year = "1997",

doi = "10.1038/sj.leu.2400523",

language = "English (US)",

volume = "11",

pages = "170",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "1",

}

TY - JOUR

T1 - Myelodysplasia following treatment of chronic lymphocytic leukemia (CLL) with 2-chlorodeoxyadenosine (2-CdA) [1]

AU - Kroft, S. H.

AU - Tallman, M. S.

AU - Shaw, J. M.

AU - Thangavelu, M.

AU - Peterson, L. C.

PY - 1997

Y1 - 1997

UR - http://www.scopus.com/inward/record.url?scp=0031042990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031042990&partnerID=8YFLogxK

U2 - 10.1038/sj.leu.2400523

DO - 10.1038/sj.leu.2400523

M3 - Letter

C2 - 9001435

AN - SCOPUS:0031042990

SN - 0887-6924

VL - 11

SP - 170

JO - Leukemia

JF - Leukemia

IS - 1

ER -

Myelodysplasia following treatment of chronic lymphocytic leukemia (CLL) with 2-chlorodeoxyadenosine (2-CdA) [1]

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Cite this